top of page
Next-gen Fermentation

Enifer secures US GRAS status for mycoprotein ingredient Pekilo

FoodBev Media logo.png

Rafaela Sousa

11 September 2025

11 September 2025

Enifer secures US GRAS status for mycoprotein ingredient Pekilo

Placeholder.png

Finnish biotech company Enifer has obtained self-affirmed GRAS (Generally Recognized as Safe) status in the US for its mycoprotein ingredient Pekilo, following an independent expert panel review.


The step paves the way for partnerships with US food manufacturers, with FDA-reviewed GRAS status still to be pursued.


According to the company, Pekilo differs from most mycoproteins by being supplied in dry, powdered form, making it shelf-stable, easier to transport and simpler to integrate into production lines. It is targeted at plant-based alternatives, sports nutrition and healthy snacks as a lower-impact alternative to soy.


“Plant-based foods won’t win over consumers unless they’re genuinely better than what came before,” said Simo Ellilä, CEO and co-founder of Enifer. “Pekilo makes that possible – it brings a neutral colour and taste, a natural combination of protein and fiber and strong water-holding capacity. These properties complement soy and pea proteins, giving food makers new flexibility to develop plant-based products that deliver better texture, nutrition and overall consumer appeal.”


Founded in 2020, Enifer uses fermentation technology first developed in Finland in the 1970s to convert food and agricultural byproducts into protein with lower land use and emissions than animal or soy-based sources.


The US entry follows Enifer’s €36 million raise in 2024 to build a commercial-scale mycoprotein facility in Finland, due to start production in 2026 with a 3,000-tonne annual capacity. The plant will initially supply the pet food sector, with food-ingredient production to follow.


Elisa Arte, head of food research and development at Enifer, added: “Achieving self-affirmed GRAS status marks a major milestone in the commercialisation of our Pekilo mycoprotein and its entry into the US market. We’re excited to start collaborating with food manufacturers in the US, introducing to the market our ingredient that delivers high levels of digestible protein and dietary fiber, enabling innovation across a broad spectrum of food applications."


Enifer will present Pekilo at SupplySide West in Las Vegas this October as it begins US market outreach.

Related news

Placeholder.png

Singapore awards $32.3m to boost alternative protein and food safety research

The Singapore Food Agency (SFA) has awarded $32.3 million in research funding to 11 projects under the second phase of the Singapore Food Story R&D Programme, aimed at advancing innovation in future foods and food safety.

Placeholder.png

The Every Co and Vivici to establish 4-million-litre alternative protein facility in Abu Dhabi

The Abu Dhabi Investment Office (ADIO) has partnered with precision fermentation specialists The Every Company and Vivici, aiming to advance an alternative protein ecosystem in the United Arab Emirates capital. Precision fermentation is an advanced biotechnology method involving the use of microorganisms to produce high-value proteins and other ingredients. Typically animal-based ingredients, such as dairy proteins, can be produced in this way with no animal input, offering a sustainable...

Placeholder.png

Enough announces Jan Agter as interim CEO

Alternative protein producer Enough has announced the appointment of Jan Agter as Interim CEO, succeeding co-founder Jim Laird.

Placeholder.png

EU unveils €350m plan to boost food innovation through fermentation technologies

The plan includes €350 million in funding to help scale up fermentation technologies that can support the development of sustainable food ingredients and alternative proteins.

Next-gen Fermentation

Enifer secures US GRAS status for mycoprotein ingredient Pekilo

FoodBev Media logo.png

Rafaela Sousa

11 September 2025

bottom of page